Clinical Factors Associated with COVID-19 Severity in Mexican Patients: Cross-Sectional Analysis from a Multicentric Hospital Study

(1) Background: Latin America has been harshly hit by SARS-CoV-2, but reporting from this region is still incomplete. This study aimed at identifying and comparing clinical characteristics of patients with COVID-19 at different stages of disease severity. (2) Methods: Cross-sectional multicentric st...

Full description

Bibliographic Details
Main Authors: Joel Monárrez-Espino, Carolina Ivette Zubía-Nevárez, Lorena Reyes-Silva, Juan Pablo Castillo-Palencia, Julio Enrique Castañeda-Delgado, Ana Sofía Herrera van-Oostdam, Yamilé López-Hernández
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Healthcare
Subjects:
Online Access:https://www.mdpi.com/2227-9032/9/7/895
_version_ 1797526970804731904
author Joel Monárrez-Espino
Carolina Ivette Zubía-Nevárez
Lorena Reyes-Silva
Juan Pablo Castillo-Palencia
Julio Enrique Castañeda-Delgado
Ana Sofía Herrera van-Oostdam
Yamilé López-Hernández
author_facet Joel Monárrez-Espino
Carolina Ivette Zubía-Nevárez
Lorena Reyes-Silva
Juan Pablo Castillo-Palencia
Julio Enrique Castañeda-Delgado
Ana Sofía Herrera van-Oostdam
Yamilé López-Hernández
author_sort Joel Monárrez-Espino
collection DOAJ
description (1) Background: Latin America has been harshly hit by SARS-CoV-2, but reporting from this region is still incomplete. This study aimed at identifying and comparing clinical characteristics of patients with COVID-19 at different stages of disease severity. (2) Methods: Cross-sectional multicentric study. Individuals with nasopharyngeal PCR were categorized into four groups: (1) negative, (2) positive, not hospitalized, (3) positive, hospitalized with/without supplementary oxygen, and (4) positive, intubated. Clinical and laboratory data were compared, using group 1 as the reference. Multivariate multinomial logistic regression was used to compare adjusted odds ratios. (3) Results: Nine variables remained in the model, explaining 76% of the variability. Men had increased odds, from 1.90 (95%CI 0.87–4.15) in the comparison of 2 vs. 1, to 3.66 (1.12–11.9) in 4 vs. 1. Diabetes and obesity were strong predictors. For diabetes, the odds for groups 2, 3, and 4 were 1.56 (0.29–8.16), 12.8 (2.50–65.8), and 16.1 (2.87–90.2); for obesity, these were 0.79 (0.31–2.05), 3.38 (1.04–10.9), and 4.10 (1.16–14.4), respectively. Fever, myalgia/arthralgia, cough, dyspnea, and neutrophilia were associated with the more severe COVID-19 group. Anosmia/dysgeusia were more likely to occur in group 2 (25.5; 2.51–259). (4) Conclusion: The results point to relevant differences in clinical and laboratory features of COVID-19 by level of severity that can be used in medical practice.
first_indexed 2024-03-10T09:37:52Z
format Article
id doaj.art-09fcce83cfd149ea89429796d9d787a2
institution Directory Open Access Journal
issn 2227-9032
language English
last_indexed 2024-03-10T09:37:52Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Healthcare
spelling doaj.art-09fcce83cfd149ea89429796d9d787a22023-11-22T03:53:00ZengMDPI AGHealthcare2227-90322021-07-019789510.3390/healthcare9070895Clinical Factors Associated with COVID-19 Severity in Mexican Patients: Cross-Sectional Analysis from a Multicentric Hospital StudyJoel Monárrez-Espino0Carolina Ivette Zubía-Nevárez1Lorena Reyes-Silva2Juan Pablo Castillo-Palencia3Julio Enrique Castañeda-Delgado4Ana Sofía Herrera van-Oostdam5Yamilé López-Hernández6Department of Health Research, Christus Muguerza del Parque Hospital, Chihuahua 31000, MexicoVice Presidency of Health Sciences, Medical Specialties Program, University of Monterrey, San Pedro Garza García 66238, MexicoDepartment of Health Research, Christus Muguerza del Parque Hospital, Chihuahua 31000, MexicoGeneral Hospital of Soledad de Graciano Sánchez, San Luis Potosí Health Services, Soledad de Graciano Sánchez 78435, MexicoBiomedical Research Unit, Mexican Institute of Social Security, Zacatecas 98000, MexicoBiochemistry Department, San Luis Potosí Autonomous University, San Luis Potosí 78290, MexicoMetabolomics and Proteomics Laboratory, Mexican Council of Science and Technology, Zacatecas Autonomous University, Zacatecas 98000, Mexico(1) Background: Latin America has been harshly hit by SARS-CoV-2, but reporting from this region is still incomplete. This study aimed at identifying and comparing clinical characteristics of patients with COVID-19 at different stages of disease severity. (2) Methods: Cross-sectional multicentric study. Individuals with nasopharyngeal PCR were categorized into four groups: (1) negative, (2) positive, not hospitalized, (3) positive, hospitalized with/without supplementary oxygen, and (4) positive, intubated. Clinical and laboratory data were compared, using group 1 as the reference. Multivariate multinomial logistic regression was used to compare adjusted odds ratios. (3) Results: Nine variables remained in the model, explaining 76% of the variability. Men had increased odds, from 1.90 (95%CI 0.87–4.15) in the comparison of 2 vs. 1, to 3.66 (1.12–11.9) in 4 vs. 1. Diabetes and obesity were strong predictors. For diabetes, the odds for groups 2, 3, and 4 were 1.56 (0.29–8.16), 12.8 (2.50–65.8), and 16.1 (2.87–90.2); for obesity, these were 0.79 (0.31–2.05), 3.38 (1.04–10.9), and 4.10 (1.16–14.4), respectively. Fever, myalgia/arthralgia, cough, dyspnea, and neutrophilia were associated with the more severe COVID-19 group. Anosmia/dysgeusia were more likely to occur in group 2 (25.5; 2.51–259). (4) Conclusion: The results point to relevant differences in clinical and laboratory features of COVID-19 by level of severity that can be used in medical practice.https://www.mdpi.com/2227-9032/9/7/895COVID-19disease severityMexicomultivariate analysissigns and symptoms
spellingShingle Joel Monárrez-Espino
Carolina Ivette Zubía-Nevárez
Lorena Reyes-Silva
Juan Pablo Castillo-Palencia
Julio Enrique Castañeda-Delgado
Ana Sofía Herrera van-Oostdam
Yamilé López-Hernández
Clinical Factors Associated with COVID-19 Severity in Mexican Patients: Cross-Sectional Analysis from a Multicentric Hospital Study
Healthcare
COVID-19
disease severity
Mexico
multivariate analysis
signs and symptoms
title Clinical Factors Associated with COVID-19 Severity in Mexican Patients: Cross-Sectional Analysis from a Multicentric Hospital Study
title_full Clinical Factors Associated with COVID-19 Severity in Mexican Patients: Cross-Sectional Analysis from a Multicentric Hospital Study
title_fullStr Clinical Factors Associated with COVID-19 Severity in Mexican Patients: Cross-Sectional Analysis from a Multicentric Hospital Study
title_full_unstemmed Clinical Factors Associated with COVID-19 Severity in Mexican Patients: Cross-Sectional Analysis from a Multicentric Hospital Study
title_short Clinical Factors Associated with COVID-19 Severity in Mexican Patients: Cross-Sectional Analysis from a Multicentric Hospital Study
title_sort clinical factors associated with covid 19 severity in mexican patients cross sectional analysis from a multicentric hospital study
topic COVID-19
disease severity
Mexico
multivariate analysis
signs and symptoms
url https://www.mdpi.com/2227-9032/9/7/895
work_keys_str_mv AT joelmonarrezespino clinicalfactorsassociatedwithcovid19severityinmexicanpatientscrosssectionalanalysisfromamulticentrichospitalstudy
AT carolinaivettezubianevarez clinicalfactorsassociatedwithcovid19severityinmexicanpatientscrosssectionalanalysisfromamulticentrichospitalstudy
AT lorenareyessilva clinicalfactorsassociatedwithcovid19severityinmexicanpatientscrosssectionalanalysisfromamulticentrichospitalstudy
AT juanpablocastillopalencia clinicalfactorsassociatedwithcovid19severityinmexicanpatientscrosssectionalanalysisfromamulticentrichospitalstudy
AT julioenriquecastanedadelgado clinicalfactorsassociatedwithcovid19severityinmexicanpatientscrosssectionalanalysisfromamulticentrichospitalstudy
AT anasofiaherreravanoostdam clinicalfactorsassociatedwithcovid19severityinmexicanpatientscrosssectionalanalysisfromamulticentrichospitalstudy
AT yamilelopezhernandez clinicalfactorsassociatedwithcovid19severityinmexicanpatientscrosssectionalanalysisfromamulticentrichospitalstudy